Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|6|574-587

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.6, 2008-02, pp. : 574-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins and Muscle Adverse Effects: A Complementary Perspective

By Golomb Beatrice A.   Koperski Sabrina  

Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. : 803-803

Adis International

Access to resources Recommend Favorite

Safety and adverse effects associated with GLP-1 analogues

By Stephens Jeffrey W   Bain Stephen C  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 417-422

Informa Healthcare

Access to resources Recommend Favorite

Adverse effects associated with SonoVue® use

By Torzilli Guido  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 399-401

Informa Healthcare

Access to resources Recommend Favorite

Low skeletal muscle is associated with toxicity in patients included in phase I trials

By Cousin Sophie   Hollebecque A.   Koscielny S.   Mir O.   Varga A.   Baracos V.   Soria J.   Antoun S.  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 382-387

Springer Publishing Company

Access to resources Recommend Favorite

USA FDA issues alert about Cylert-associated liver toxicity

By  

Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite